PAWC
P.A.W. Capital Portfolio holdings
AUM
$51.9M
This Quarter Return
+6.83%
1 Year Return
+46.14%
3 Year Return
+74.13%
5 Year Return
+167.35%
10 Year Return
+839.74%
AUM
$92.5M
AUM Growth
+$92.5M
(+4.1%)
Cap. Flow
+$1.07M
Cap. Flow
% of AUM
1.16%
Top 10 Holdings %
Top 10 Hldgs %
40.67%
Holding
70
New
7
Increased
12
Reduced
18
Closed
6
Top Buys
| 1 |
CareCloud
CCLD
|
$2.27M |
| 2 |
Ambarella
AMBA
|
$1.77M |
| 3 |
EverQuote
EVER
|
$1.56M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$1.47M |
| 5 |
Apyx Medical
APYX
|
$806K |
Top Sells
| 1 |
Semler Scientific
SMLR
|
$1.37M |
| 2 |
Krystal Biotech
KRYS
|
$1.15M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$943K |
| 4 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$838K |
| 5 |
Chegg
CHGG
|
$772K |
Sector Composition
| 1 | Technology | 32.34% |
| 2 | Healthcare | 20% |
| 3 | Communication Services | 16.88% |
| 4 | Consumer Staples | 8.59% |
| 5 | Industrials | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Varonis Systems
VRNS
$6.61B
| $1.24M | 1.34% |
20,000
-5,000
| -20% | -$310K |
|
|
ASPU
27
DELISTED
ASPEN GROUP, INC.
ASPU
| $1.14M | 1.23% |
300,000
+50,000
| +20% | +$190K |
|
28
AT&T
T
$209B
| $838K | 0.91% |
25,000
| – | – |
|
|
29
Apyx Medical
APYX
$75.3M
| $806K | 0.87% |
+120,000
| New | +$806K |
|
|
RDS.A
30
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $781K | 0.84% |
12,000
| – | – |
|
31
PepsiCo
PEP
$204B
| $721K | 0.78% |
5,500
| – | – |
|
32
Ares Capital
ARCC
$15.8B
| $718K | 0.78% |
40,000
| – | – |
|
33
Abbott
ABT
$231B
| $715K | 0.77% |
8,500
-500
| -6% | -$42.1K |
|
34
Merck
MRK
$210B
| $713K | 0.77% |
8,500
-500
| -6% | -$41.9K |
|
35
Procter & Gamble
PG
$368B
| $713K | 0.77% |
6,500
| – | – |
|
36
BlackRock TCP Capital
TCPC
$613M
| $713K | 0.77% |
50,000
+5,000
| +11% | +$71.3K |
|
37
Johnson & Johnson
JNJ
$427B
| $696K | 0.75% |
5,000
| – | – |
|
38
Exxon Mobil
XOM
$487B
| $690K | 0.75% |
9,000
+1,000
| +13% | +$76.7K |
|
39
Verizon
VZ
$186B
| $686K | 0.74% |
12,000
| – | – |
|
40
Chevron
CVX
$324B
| $684K | 0.74% |
5,500
| – | – |
|
41
JPMorgan Chase
JPM
$829B
| $671K | 0.73% |
6,000
| – | – |
|
42
Microsoft
MSFT
$3.77T
| $670K | 0.72% |
5,000
| – | – |
|
43
BP
BP
$90.8B
| $667K | 0.72% |
16,000
| – | – |
|
44
Coca-Cola
KO
$297B
| $662K | 0.72% |
13,000
| – | – |
|
45
Blackstone
BX
$134B
| $660K | 0.71% |
15,000
| – | – |
|
46
Weyerhaeuser
WY
$18.7B
| $659K | 0.71% |
25,000
| – | – |
|
47
Morgan Stanley
MS
$240B
| $657K | 0.71% |
15,000
| – | – |
|
48
Pfizer
PFE
$141B
| $650K | 0.7% |
15,000
| – | – |
|
49
GSK
GSK
$79.9B
| $640K | 0.69% |
16,000
| – | – |
|
50
Philip Morris
PM
$260B
| $628K | 0.68% |
8,000
| – | – |
|